Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Sae-Hoon Kim, Tae-Wan Kim, Jae-Woo Kwon, Hye-Ryun Kang, Yong-Won Lee, Tae-Bum Kim, Sang-Heon Kim, Heung-Woo Park, Sung-Woo Park, Yoon-Seok Chang, You-Sook Cho, Jung-Won Park, Young-Joo Cho, Ho-Joo Yoon, Sang-Heon Cho, Byoung-Whui Choi, Hee-Bom Moon & Kyung-Up Min. (2012) Economic Costs for Adult Asthmatics According to Severity and Control Status in Korean Tertiary Hospitals. Journal of Asthma 49:3, pages 303-309.
Read now
Read now
Articles from other publishers (30)
Denis Vinnikov, Aizhan Raushanova, Irina Mukatova, Tair Nurpeissov, Assia Кushekbayeva, Assiya Toxarina, Baktygul Yessimova, Fatima Bespayeva & Nurlan Brimkulov. (2023) Asthma control in Kazakhstan: need for urgent action. BMC Pulmonary Medicine 23:1.
Crossref
Crossref
Luana Andrade Macedo, Rafaella de Oliveira Santos Silva, Carina Carvalho Silvestre, Thaciana dos Santos Alcântara, Sílvia de Magalhães Simões & Divaldo Pereira Lyra Jr. (2021) Effect of pharmacists’ interventions on health outcomes of children with asthma: A systematic review. Journal of the American Pharmacists Association 61:3, pages e28-e43.
Crossref
Crossref
Mina Nicola, Ahmed A. Elberry, Ossama M. Sayed, Raghda R.S. Hussein & Mohamed E.A. Abdelrahim. (2018) Effect of DPI's training-device on inhalation technique and clinical efficacy in asthmatics. Beni-Suef University Journal of Basic and Applied Sciences 7:2, pages 178-183.
Crossref
Crossref
Manuel Ferreira de Magalhães, Rita Amaral, Ana M. Pereira, Ana Sá-Sousa, Inês Azevedo, Luís F. Azevedo & João A. Fonseca. (2017) Cost of asthma in children: A nationwide, population-based, cost-of-illness study. Pediatric Allergy and Immunology 28:7, pages 683-691.
Crossref
Crossref
Ian D. Pavord, Nicola Mathieson, Anna Scowcroft, Riccardo Pedersini, Gina Isherwood & David Price. (2017) The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β2-agonists in the United Kingdom: a cross-sectional analysis. npj Primary Care Respiratory Medicine 27:1.
Crossref
Crossref
M. Sadatsafavi, W. Chen, H. Tavakoli, J. D. Rolf, R. Rousseau & J. M. FitzGerald. (2016) Saving in medical costs by achieving guideline-based asthma symptom control: a population-based study. Allergy 71:3, pages 371-377.
Crossref
Crossref
Alpár Horváth, Ágnes Jókay, Árpád Farkas & Gábor Tomisa. (2015) The characteristics of diagnosis, patient care and education of asthma and COPD patients from the perspective of the actors in the Hungarian healthcare system. Journal of Public Health 24:1, pages 21-29.
Crossref
Crossref
Marwa O. Elgendy, Mohamed E. Abdelrahim & Randa Salah Eldin. (2015) Potential Benefit of Repeated Dry Powder Inhaler’s Inhalation Technique Counseling on Asthmatic Patients. Pulmonary Therapy 1:1, pages 91-101.
Crossref
Crossref
Mohsen Sadatsafavi, Roxanne Rousseau, Wenjia Chen, Wei Zhang, Larry Lynd & J. Mark FitzGerald. (2014) The Preventable Burden of Productivity Loss Due to Suboptimal Asthma Control. Chest 145:4, pages 787-793.
Crossref
Crossref
D. Price, S. Bosnic-Anticevich, A. Briggs, H. Chrystyn, C. Rand, G. Scheuch & J. Bousquet. (2013) Inhaler competence in asthma: Common errors, barriers to use and recommended solutions. Respiratory Medicine 107:1, pages 37-46.
Crossref
Crossref
Stanley J. Szefler, Robert S. Zeiger, Tmirah Haselkorn, David R. Mink, Tripthi V. Kamath, James E. Fish & Bradley E. Chipps. (2011) Economic burden of impairment in children with severe or difficult-to-treat asthma. Annals of Allergy, Asthma & Immunology 107:2, pages 110-119.e1.
Crossref
Crossref
A.J. Blasco Bravo, E.G. Pérez-Yarza, P. Lázaro y de Mercado, A. Bonillo Perales, C.A. Díaz Vazquez & A. Moreno Galdó. (2011) Coste del asma en pediatría en España: un modelo de evaluación de costes basado en la prevalencia. Anales de Pediatría 74:3, pages 145-153.
Crossref
Crossref
P. Demoly, B. Gueron, K. Annunziata, L. Adamek & R. D. Walters. (2010) Update on asthma control in five European countries: results of a 2008 survey. European Respiratory Review 19:116, pages 150-157.
Crossref
Crossref
Adam Atherly. 2010. Asthma, Health and Society. Asthma, Health and Society
325
334
.
Katayoun Bahadori, Mary M Doyle-Waters, Carlo Marra, Larry Lynd, Kadria Alasaly, John Swiston & Js Mark FitzGerald. (2009) Economic burden of asthma: a systematic review. BMC Pulmonary Medicine 9:1.
Crossref
Crossref
Mike Thomas, David Price, Henry Chrystyn, Andrew Lloyd, Angela E Williams & Julie von Ziegenweidt. (2009) Inhaled corticosteroids for asthma: impact of practice level device switching on asthma control. BMC Pulmonary Medicine 9:1.
Crossref
Crossref
Tmirah Haselkorn, Robert S. Zeiger, Bradley E. Chipps, David R. Mink, Stanley J. Szefler, F. Estelle R. Simons, Marc Massanari & James E. Fish. (2009) Recent asthma exacerbations predict future exacerbations in children with severe or difficult-to-treat asthma. Journal of Allergy and Clinical Immunology 124:5, pages 921-927.
Crossref
Crossref
P.T.R. Dalcin, D.M. Menegotto, A. Zanonato, L. Franciscatto, F. Soliman, M. Figueiredo & R.P. Pereira. (2009) Factors associated with uncontrolled asthma in Porto Alegre, Brazil. Brazilian Journal of Medical and Biological Research 42:11, pages 1097-1103.
Crossref
Crossref
Andrew Briggs, Helen Starkie & Olivia Wu. 2009. Asthma and COPD. Asthma and COPD
751
760
.
Michael Schatz. 2009. Allergy Frontiers: Diagnosis and Health Economics. Allergy Frontiers: Diagnosis and Health Economics
507
541
.
Anna Nowak, Aleksandra Kosm?da & Andrzej Bozna?ski. (2008) Koszty leczenia szpitalnego zaostrze? astmy oskrzelowej u dzieci. Pediatria Polska 83:1, pages 39-44.
Crossref
Crossref
Njira L. Lugogo, Monica Kraft & Mario Castro. 2008. Clinical Asthma. Clinical Asthma
3
12
.
N. Ait-Khaled, D. A. Enarson, K. Bissell & N. E. Billo. (2007) Access to inhaled corticosteroids is key to improving quality of care for asthma in developing countries. Allergy 62:3, pages 230-236.
Crossref
Crossref
Stephen T Holgate, David Price & Erkka Valovirta. (2006) Asthma out of control? A structured review of recent patient surveys. BMC Pulmonary Medicine 6:S1.
Crossref
Crossref
James Kemp. (2006) Is there a best outcome measurement for patients with asthma?. Annals of Allergy, Asthma & Immunology 97:4, pages 432-439.
Crossref
Crossref
P. M. Gustafsson, L. Watson, K. J. Davis & K. F. Rabe. (2006) Poor asthma control in children: evidence from epidemiological surveys and implications for clinical practice. International Journal of Clinical Practice 60:3, pages 321-334.
Crossref
Crossref
Njira L. Lugogo & Monica Kraft. (2006) Epidemiology of Asthma. Clinics in Chest Medicine 27:1, pages 1-15.
Crossref
Crossref
Ebere Akobundu, Jing Ju, Lisa Blatt & C Daniel Mullins. (2006) Cost-of-Illness Studies. PharmacoEconomics 24:9, pages 869-890.
Crossref
Crossref
Karna Gendo & Matthew J Lodewick. (2005) Asthma economics: focusing on therapies that improve costly outcomes. Current Opinion in Pulmonary Medicine 11:1, pages 43-50.
Crossref
Crossref
Gülfem E. Çelik, Sevim Bavbek, Gülden Paşaoğlu, Dilşad Mungan, Öznur Abadoğlu, Emel Harmancı & Zeynep Mısırlıgil. (2004) Direct Medical Cost of Asthma in Ankara, Turkey. Respiration 71:6, pages 587-593.
Crossref
Crossref